MRNA
NASDAQ · Biotechnology
Moderna Inc
$241.46
-16.92 (-6.55%)
Analyst Consensus
Hold
31
Analysts
Very High
Coverage
Price Target
Analyst Price Target
-38.1% upside
Low Target
$89.97
Average Target
$149.45
High Target
$212.09
Current Price
$241.46
Current
$241.46
$241.46
Target
$149.45
$149.45
$89.97
$149.45 avg
$212.09
Scenario Analysis
Bear Case
$89.97
-62.7%
Low target
Base Case
$149.45
-38.1%
Avg target
Bull Case
$212.09
+-12.2%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$254.48
-5.1% from high
52-Week Low
$22.28
+983.8% from low
50-Day SMA
$187.78
+28.6% vs SMA
200-Day SMA
$89.50
+169.8% vs SMA
RSI (14)
57.0
Neutral
Target vs 52W High
$149.45
-41.3% vs high
Next Earnings Report
Nov 6, 2026 · Before Market Open
Today
EPS Est: $-1.28
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -10.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +116.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 35% | $149.45 | -38.1% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -60.7% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -35.8% |